Get FREE U.S. Shipping on $75 Orders*

Oral treatment of late Lyme borreliosis with a combination of roxithromycin and co-trimoxazole–a pilot study on 18 patients.

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

Abstract

In this pilot trial, 18 patients participated in an investigation in which the combined therapy of co-trimoxazole and roxithromycin in late
Lyme borreliosis was tested. The study has been performed as a result of earlier case reports in “The Lancet” where this combination has been used successfully in order to thwart late
Lyme disease. The authors show that 76% of the patients recovered completely. In 2 patients, symptoms could be resolved with i.v. penicillin and 2 did not respond to any antibiotic therapy. These results show that oral therapy of co-trimoxazole and roxithromycin in combination provides similar results as i.v. antibiotics in earlier studies.

Acta Med Austriaca. 1996;23(3):99-101.

ProHealth CBD Store

 

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...



Leave a Reply